snmchepatitis

由洪業晃著作·2006·被引用1次—InterferoncombinedribavirintherapyinchronichepatitisCwasastandardprincipleexceptnon-respondersorrelapse's.StrongerNeo-MinophagenC(SNMC)isa ...,AcutehepatitisBvirus(HBV)isoneofthemostcommoncausesoffulminanthepatitis,especiallyintheendemicarea....SNMCwereusedfortotal15days.,由LZhang著作·2000·被引用21次—SNMCwasprovedtobesafewithminimalsideeffects.Introduction.Hepatitis...

參考資訊如下
甘草甜素對慢性C型肝炎血清生化值的臨床觀察

由 洪業晃 著作 · 2006 · 被引用 1 次 — Interferon combined ribavirin therapy in chronic hepatitis C was a standard principle except non-responders or relapse's. Stronger Neo-Minophagen C (SNMC) is a ...

中文題目：使用惠立妥, 貝樂克雙線抗病毒藥物合併靜脈注射 ...

Acute hepatitis B virus (HBV) is one of the most common causes of fulminant hepatitis, especially in the endemic area. ... SNMC were used for total 15 days.

Therapeutic effects of Stronger Neo

由 L Zhang 著作 · 2000 · 被引用 21 次 — SNMC was proved to be safe with minimal side effects. Introduction. Hepatitis B virus (HBV) is the leading cause of liver disease in China, threatening ...

Evaluation of Stronger Neo-Minophagen

由 K Reddyvari 著作 · 2015 · 被引用 1 次 — There is increasing evidence to indicate the therapeutic efficacy of SNMC in normalizing liver function tests (LFT) in patients with acute hepatitis. Objectives ...

Efficacy and safety of stronger neo

OBJECTIVE: To compare the efficacy and safety of Stronger Neo-Minophagen C (SNMC) in the treatment of chronic hepatitis B. METHODS: We searched MEDLINE, EMBASE, ...

SNMC (Stronger Neo

SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy. The safety and scientific validity of this study is the ...

Long

由 H Kumada 著作 · 2002 · 被引用 264 次 — Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.

Benefits of stronger Neo‐Minophagen C in acute hepatitis ...

由 WC Huang 著作 · 2023 · 被引用 1 次 — Stronger Neo-Minophagen C (SNMC) has demonstrated benefits in patients with hepatitis. We aimed to determine its usefulness in post-TACE ...

奇美醫院胃腸肝膽科

2021年6月10日 — 1, 黃文杰(1), Benefits of SNMC (Stronger Neo-Minophagen C ) for acute hepatitis post transarterial chemoembolization therapy on hepatoma patient.